Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity

Neurobiology of Disease

Volumn 33, Issue 3, 2009, Pages 405-414

  Sandhu, Jagdeep K ^a   Gardaneh, Mossa ^a   Iwasiow, Rafal ^a   Lanthier, Patricia ^a   Gangaraju, Sandhya ^a   Ribecco Lutkiewicz, Maria ^a   Tremblay, Roger ^a   Kiuchi, Kazutoshi ^b   Sikorska, Marianna ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Coculture; Gene therapy; Lentiviral vector; Neuro regeneration; Neuroprotection; Neurotrophic factor; Oxidative stress; Signal transduction; Thiol antioxidant; Viral vectors

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; GENE CONTROL; GENE OVEREXPRESSION; IN VITRO STUDY; LENTIVIRINAE; MACROGLIA; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; TRANSGENE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; ASTROCYTES; BLOTTING, WESTERN; BUTHIONINE SULFOXIMINE; CELL SURVIVAL; COCULTURE TECHNIQUES; GENE EXPRESSION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLUTATHIONE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEURONS; OXIDOPAMINE; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 61349183716     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.11.016     Document Type: Article

References (56)

1. Airaksinen M.S., and Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3 (2002) 383-394
2. Akerud P., Canals J.M., Snyder E.Y., and Arenas E. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J. Neurosci. 21 (2001) 8108-8118
3. Arvidsson A., Kirik D., Lundberg C., Mandel R.J., Andsberg G., Kokaia Z., and Lindvall O. Elevated GDNF levels following viral vector-mediated gene transfer can increase neuronal death after stroke in rats. Neurobiol. Dis. 14 (2003) 542-556
4. Bohn M.C. Motoneurons crave glial cell line-derived neurotrophic factor. Exp. Neurol. 190 (2004) 263-275
5. Byrd A.S., Sikorska M., Walker P.R., and Sandhu J.K. Effects of glutathione depletion on the viability of human NT2-derived neuronal and astroglial cultures. Neuron Glia Biology 1 (2004) 317-326
6. Capowski E.E., Schneider B.L., Ebert A.D., Seehus C.R., Szulc J., Zufferey R., Aebischer P., and Svendsen C.N. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. J. Neurosci. Methods. 163 (2007) 338-349
7. Cunningham L.A., and Su C. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. Exp. Neurol. 174 (2002) 230-242
8. Ding Y.M., Jaumotte J.D., Signore A.P., and Zigmond M.J. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. J. Neurochem. 89 (2004) 776-787
9. Dringen R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 62 (2000) 649-671
10. Dringen R., and Hirrlinger J. Glutathione pathways in the brain. Biol. Chem. 384 (2003) 505-516
11. Dringen R., Gutterer J.M., and Hirrlinger J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267 (2000) 4912-4916
12. Duan D., Yang H., Zhang J., Zhang J., and Xu Q. Long-term restoration of nigrostriatal system function by implanting GDNF genetically modified fibroblasts in a rat model of Parkinson's disease. Exp. Brain Res. 161 (2005) 316-324
13. Ericson C., Georgievska B., and Lundberg C. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease. Eur. J. Neurosci. 22 (2005) 2755-2764
14. Eslamboli A. Assessment of GDNF in primate models of Parkinson's disease: comparison with human studies. Rev. Neurosci. 16 (2005) 303-310
15. Galan-Rodriguez B., del-Marco A., Flores J.A., Ramiro-Fuentes S., Gonzalez-Aparicio R., Tunez I., Tasset I., and Fernandez-Espejo E. Grafts of extra-adrenal chromaffin cells as aggregates show better survival rate and regenerative effects on parkinsonian rats than dispersed cell grafts. Neurobiol. Dis. 29 (2008) 529-542
16. Garcia-Martinez J.M., Perez-Navarro E., Gavalda N., and Alberch J. Glial cell line-derived neurotrophic factor promotes the arborization of cultured striatal neurons through the p42/p44 mitogen-activated protein kinase pathway. J. Neurosci. Res. 83 (2006) 68-79
17. Georgievska B., Kirik D., and Bjorklund A. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 177 (2002) 461-474
18. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., and Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9 (2003) 589-595
19. Horita Y., Honmou O., Harada K., Houkin K., Hamada H., and Kocsis J.D. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J. Neurosci. Res. 84 (2006) 1495-1504
20. Iwata-Ichikawa E., Kondo Y., Miyazaki I., Asanuma M., and Ogawa N. Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis. J Neurochem 72 (1999) 2334-2344
21. Jakobsson J., and Lundberg C. Lentiviral vectors for use in the central nervous system. Mol. Ther. 13 (2006) 484-493
22. Kafri T. Gene delivery by lentivirus vectors an overview. Methods Mol. Biol. 246 (2004) 367-390
23. Karakaya S., Kipp M., and Beyer C. Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system. J. Neuroendocrinol. 19 (2007) 682-690
24. Klein S.M., Behrstock S., McHugh J., Hoffmann K., Wallace K., Suzuki M., Aebischer P., and Svendsen C.N. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum. Gene Ther. 16 (2005) 509-521
25. Kobayashi T., Ahlenius H., Thored P., Kobayashi R., Kokaia Z., and Lindvall O. Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke 37 (2006) 2361-2367
26. Kordower J.H., Palfi S., Chen E.Y., Ma S.Y., Sendera T., Cochran E.J., Cochran E.J., Mufson E.J., Penn R., Goetz C.G., and Comella C.D. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann. Neurol. 46 (1999) 419-424
27. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., and Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290 (2000) 767-773
28. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., and Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260 (1993) 1130-1132
29. Matsushita N., Fujita Y., Tanaka M., Nagatsu T., and Kiuchi K. Cloning and structural organization of the gene encoding the mouse glial cell line-derived neurotrophic factor, GDNF. Gene 203 (1997) 149-157
30. McBride J.L., During M.J., Wuu J., Chen E.Y., Leurgans S.E., and Kordower J.H. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. Exp. Neurol. 181 (2003) 213-223
31. McBride J.L., Ramaswamy S., Gasmi M., Bartus R.T., Herzog C.D., Brandon E.P., Zhou L., Pitzer M.R., Berry-Kravis E.M., and Kordower J.H. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 9345-9350
32. Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 263 (1988) 17205-17208
33. Mikaels-Edman A., Baudet C., and Ernfors P. Soluble and bound forms of GFRalpha1 elicit different GDNF-independent neurite growth responses in primary sensory neurons. Dev. Dyn. 227 (2003) 27-34
34. Oppenheim R.W., Houenou L.J., Johnson J.E., Lin L.F., Li L., Lo A.C., Newsome A.L., Prevette D.M., and Wang S. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373 (1995) 344-346
35. Parsadanian A., Pan Y., Li W., Myckatyn T.M., and Brakefield D. Astrocyte-derived transgene GDNF promotes complete and long-term survival of adult facial motoneurons following avulsion and differentially regulates the expression of transcription factors of AP-1 and ATF/CREB families. Exp. Neurol. 200 (2006) 26-37
36. Paveliev M., Lume M., Velthut A., Phillips M., Arumae U., and Saarma M. Neurotrophic factors switch between two signaling pathways that trigger axonal growth. J. Cell Sci. 120 (2007) 2507-2516
37. Pertusa M., Garcia-Matas S., Mammeri H., Adell A., Rodrigo T., Mallet J., Cristofol R., Sarkis C., and Sanfeliu C. Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats. Neurobiol. Aging 29 (2007) 1366-1379
38. Peuchen S., Bolanos J.P., Heales S.J., Almeida A., Duchen M.R., and Clark J.B. Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system. Prog. Neurobiol. 52 (1997) 261-281
39. Poteryaev D., Titievsky A., Sun Y.F., Thomas-Crusells J., Lindahl M., Billaud M., Arumae U., and Saarma M. GDNF triggers a novel ret-independent Src kinase family-coupled signaling via a GPI-linked GDNF receptor alpha1. FEBS Lett. 463 (1999) 63-66
40. Raicevic N., Mladenovic A., Perovic M., Miljkovic D., and Trajkovic V. The mechanisms of 6-hydroxydopamine-induced astrocyte death. Ann. N. Y. Acad. Sci. 1048 (2005) 400-405
41. Rosenblad C., Georgievska B., and Kirik D. Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system. Eur. J Neurosci. 17 (2003) 260-270
42. Saarma M., and Sariola H. Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF). Microsc. Res. Tech. 45 (1999) 292-302
43. Sandhu J.K., Sikorska M., and Walker P.R. Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells. J. Neurosci. Res. 68 (2002) 604-614
44. Sandhu J.K., Pandey S., Ribecco M., Monette R., Borowy-Borowski H., Walker P.R., and Sikorska M. Molecular mechanisms of glutamate neurotoxicity in mixed cultures of NT2-derived neurons and astrocytes: protective effects of coenzyme Q10. J. Neurosci. Res. 72 (2003) 691-703
45. Sariola H., and Saarma M. Novel functions and signalling pathways for GDNF. J. Cell Sci. 116 (2003) 3855-3862
46. Sherer T.B., Fiske B.K., Svendsen C.N., Lang A.E., and Langston J.W. Crossroads in GDNF therapy for Parkinson's disease. Mov. Disord. 21 (2006) 136-141
47. Takuma K., Baba A., and Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol. 72 (2004) 111-127
48. Trendelenburg G., and Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 50 (2005) 307-320
49. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 7 (2000) 20-23
50. Trupp M., Scott R., Whittemore S.R., and Ibanez C.F. Ret-dependent and independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J. Biol. Chem. 274 (1999) 20885-20894
51. Wang H.J., Cao J.P., Yu J.K., and Gao D.S. Role of PI3-K/Akt pathway and its effect on glial cell line-derived neurotrophic factor in midbrain dopamine cells. Acta Pharmacol. Sin. 28 (2007) 166-172
52. Wang L.J., Lu Y.Y., Muramatsu S., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Matsushita T., Hanazono Y., Kume A., Nagatsu T., Ozawa K., and Nakano I. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurosci. 22 (2002) 6920-6928
53. Wilson J.X. Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol. 75 (1997) 1149-1163
54. Wong L.F., Goodhead L., Prat C., Mitrophanous K.A., Kingsman S.M., and Mazarakis N.D. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum. Gene Ther. 17 (2006) 1-9
55. Zhao Z., Alam S., Oppenheim R.W., Prevette D.M., Evenson A., and Parsadanian A. Overexpression of glial cell line-derived neurotrophic factor in the CNS rescues motoneurons from programmed cell death and promotes their long-term survival following axotomy. Exp. Neurol. 190 (2004) 356-372
56. Zurn A.D., Widmer H.R., and Aebischer P. Sustained delivery of GDNF: towards a treatment for Parkinson's disease. Brain Res. Brain Res. Rev 36 (2001) 222-229